AggreWell plates
Tuesday, 27 January, 2009
Many protocols to differentiate human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) require the formation of embryoid bodies (EBs). Current methods for doing this are not reproducible and result in EBs that are heterogeneous in size and shape , leading to inefficient and uncontrolled differentiation. AggreWell plates contain microwells which can be used to aggregate hESCs and hiPSCs into uniform EBs. The AggreWell plate can be used to control the size of the EBs, allowing optimisation of differentiation protocols to specific lineages. The AggreWell plate standardises the production of EBs, reducing the variability associated with hESC and hiPSC differentiation.
StemCell Technologies
Email: cyndy.nauer@stemcell.com
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
Potential biological targets for vascular dementia
Caused by damage to blood vessels in the brain, there is currently no approved treatment for...
